Results 51 to 60 of about 1,306 (146)

Sialoadhesin Promotes the Inflammatory Response in Experimental Autoimmune Uveoretinitis [PDF]

open access: yesThe Journal of Immunology, 2006
Abstract Macrophages are a prominent component of the effector cell compartment in a number of CD4+ T cell-mediated organ-specific autoimmune diseases. In this study, we investigated the role of the sialic acid binding Ig-like lectin sialoadhesin (Sn, Siglec-1) in a model of interphotoreceptor retinal binding protein peptide-induced ...
Hui-Rong, Jiang   +5 more
openaire   +2 more sources

Infection control in the brain and the eye

open access: yesActa Ophthalmologica, Volume 104, Issue 5, Page e478-e490, August 2026.
Abstract The Central Nervous System (CNS), comprising the brain and the eye, is considered to have a ‘privileged’ mechanism for dealing with immunological challenge (immune privilege, IP). CNS IP has been revealed through experiments using foreign protein antigens and cell and tissue alloantigens (grafts), but evidence for a role for IP in modulating ...
John V. Forrester   +2 more
wiley   +1 more source

Involvement of Angiopoietin 2 and vascular endothelial growth factor in uveitis.

open access: yesPLoS ONE, 2023
PurposeAngiopoietin (Ang) 2 is released from vascular endothelial cells by the stimulation of vascular endothelial growth factor (VEGF)A. Ang2 increases the expression of leukocyte adhesion molecules on endothelial cells via nuclear factor κB. The aim of
Kayo Suzuki   +8 more
doaj   +1 more source

CD44 Participates to Extramedullary Haematopoiesis Onset by Mediating the Interplay Between Monocytes and Haematopoietic Stem Cells in Myelofibrosis

open access: yesJournal of Cellular and Molecular Medicine, Volume 29, Issue 14, July 2025.
ABSTRACT Extramedullary haematopoiesis (EMH) refers to blood generation outside of the bone marrow (BM). In Myelofibrosis (MF), a myeloproliferative neoplasm, the disruption of BM microenvironment promotes haematopoietic stem and progenitor cells (HSPCs) mobilisation, resulting in the onset of EMH in the spleen, and then in splenomegaly.
Margherita Mirabile   +24 more
wiley   +1 more source

Nanotherapy for Neural Retinal Regeneration

open access: yesAdvanced Science, Volume 12, Issue 24, June 26, 2025.
Nanotechnology enhances ophthalmic treatments by improving drug delivery and regenerating ocular tissues, combating vision loss from retinal diseases through innovative nano‐systems. This review outlines ocular anatomy, pathology, immune microenvironment, and barriers, detailing nanocarrier characteristics, classification, and preparation methods, and ...
Chuyao Yu   +11 more
wiley   +1 more source

Quantitative Characterization of Autoimmune Uveoretinitis in an Experimental Mouse Model

open access: yesInvestigative Opthalmology & Visual Science, 2017
To accurately evaluate the autoimmune inflammation, we aim to develop three quantitative measurements to monitor the inflammatory changes in the retina: retinal-choroidal thickness, major retinal vessel diameter, and electroretinography amplitudes.During a 21-day experimental period, eyes were examined by confocal scanning laser ophthalmoscopy, optical
Jian, Li   +8 more
openaire   +2 more sources

Rhodopsin-induced experimental autoimmune uveoretinitis in monkeys. [PDF]

open access: yesBritish Journal of Ophthalmology, 1989
We present the first evidence that purified rhodopsin can induce experimental autoimmune uveoretinitis (EAU) in monkeys. Injection of a highly purified lipid-free rhodopsin preparation provokes severe chorioretinitis with concomitant anterior uveitis.
J J, Schalken   +4 more
openaire   +2 more sources

Understanding exosomes: Part 2—Emerging leaders in regenerative medicine

open access: yesPeriodontology 2000, Volume 94, Issue 1, Page 257-414, February 2024.
Abstract Exosomes are the smallest subset of extracellular signaling vesicles secreted by most cells with the ability to communicate with other tissues and cell types over long distances. Their use in regenerative medicine has gained tremendous momentum recently due to their ability to be utilized as therapeutic options for a wide array of diseases ...
Richard J. Miron   +3 more
wiley   +1 more source

Development of Clarstatin, a Novel Drug Lead for the Therapy of Autoimmune Uveitis

open access: yesPharmaceutics
We describe the design, synthesis, and activity of a potent thiourea-bridged backbone cyclic peptidomimetic known as Clarstatin, comprising a 5-amino acid sequence (Q/D)1-(R/K)2-X3-X4-A5-(Gln/Asp)1-(Arg/Lys)2-AA3-AA4-Ala5-based on a motif called “shared ...
Shira Merzbach   +4 more
doaj   +1 more source

Use of optical coherence tomography and electroretinography to evaluate retinal pathology in a mouse model of autoimmune uveitis.

open access: yesPLoS ONE, 2013
Experimental autoimmune uveoretinitis (EAU) in mice is a model for human autoimmune uveitis. Longitudinal follow-up is only possible by non-invasive techniques, but the information obtained by visual fundus examination can be limited.
Jun Chen   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy